HUP0101158A3
(en )
2004-11-29
Use of glycogen phosphorylase inhibitors for the preparation of pharmaceutical compositions for the prophylactic treatment of type 2 diabetes mellitus
IL245956A0
(en )
2016-07-31
Immunogenic preparations for the prevention and treatment of inflammatory bowel disease
AU2002358348A1
(en )
2003-07-09
Soft drink replacer
HK1059215A1
(en )
2004-06-25
Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
WO2001096353A3
(en )
2002-04-18
3'-PRODRUGS OF 2'-DEOXY-β-L-NUCLEOSIDES
WO1999052515A3
(de )
2000-01-20
Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen
WO2001066564A3
(en )
2002-01-03
Gamma-secretase inhibitors
WO2001090091A8
(en )
2002-07-25
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
CA2363990A1
(en )
2002-05-24
Use of glycyrrhizin in the treatment of mastitis
ZA200105384B
(en )
2002-01-31
Use of an organometallic compound to protect and/or strengthen keratin materials and treatment process.
CA2341031A1
(en )
2000-03-02
Novel salt form of pantoprazole
WO2002028426A8
(en )
2002-06-06
Split enveloped virus preparation
CA2436540A1
(en )
2002-05-10
Pharmaceutical compositions based on anticholinergics and corticosteroids
WO1998032428A3
(en )
1998-11-12
Compositions comprising choline and use of choline to treat endotoxic shock
EP2138175A3
(en )
2010-01-13
Formulations comprising valsartan for treating diabetes or microalbuminuria
JP2002322086A5
(no )
2007-09-06
WO2001076601A3
(en )
2002-02-21
Pharmaceutical compositions comprising salmeterol and ipratropium
WO2001085188A3
(en )
2002-04-18
Use of echinacea as a hematinic agent
WO2002053149A3
(de )
2003-12-11
Arzneimittel enthaltend ein polyamin als wirksubstanz
WO2001043705A3
(en )
2001-12-13
Compositions containing a retinoid and a stilbene for skin care
IL236509A0
(en )
2015-02-26
Use of one or more HBV antigens for the preparation of oral pharmaceutical preparations for the treatment of a person with active HBV infection or hepatocellular carcinoma
WO2002046225A3
(en )
2004-01-08
Use of sarp-1 for the treatment and/or prevention of scleroderma
EP1161948A3
(en )
2003-01-08
Pharmaceutical or food composition for treatment of brain edema
MXPA02011608A
(es )
2003-10-06
Metodos para la prevencion de ulceras.
MD980129A
(en )
2000-04-30
Antiherpetic remedy